Trey has spent his career supporting informed strategic decision-making for companies operating in the life sciences field. He has experience driving over 250 consulting engagements to enhance the corporate and business development efforts of clients across therapeutic areas, including the facilitation of strategic transactions totaling over $750 M in total deal value. Prior to joining LifeSci, Trey was a project lead at ClearView Healthcare Partners managing strategy consulting mandates for big pharma and innovative biotech organizations; he also conducted biomedical and engineering research within the Van Tassel lab group. Trey received a B.S. in Chemical Engineering from Yale University.